Finanzen von Prophase Labs Inc (PRPH)PRPHProphase Labs Inc

Prophase Labs Inc (PRPH) generates its revenue primarily from Consumer products, which accounts for 100.0% of total sales, equivalent to $1.25M. Understanding this concentration is critical for investors evaluating how PRPH navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, Prophase Labs Inc maintains a gross margin of -13.93%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -539.52%, while the net margin is -774.52%. These profitability ratios, combined with a Return on Equity (ROE) of -220.34%, provide a clear picture of how effectively PRPH converts its operational activities into shareholder value.

In the context of the broader market, PRPH competes directly with industry leaders such as PAVS and MEHA. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, PRPH's gross margin of -13.93% stands against PAVS's 19.98% and MEHA's 58.41%. Such benchmarking helps identify whether Prophase Labs Inc is trading at a premium or discount relative to its financial performance.